Literature DB >> 20920632

Methodology for ventilation/perfusion SPECT.

Marika Bajc1, Brian Neilly, Massimo Miniati, Jan Mortensen, Björn Jonson.   

Abstract

Ventilation/perfusion single-photon emission computed tomography (V/Q SPECT) is the scintigraphic technique of choice for the diagnosis of pulmonary embolism and many other disorders that affect lung function. Data from recent ventilation studies show that the theoretic advantages of Technegas over radiolabeled liquid aerosols are not restricted to the presence of obstructive lung disease. Radiolabeled macroaggregated human albumin is the imaging agent of choice for perfusion scintigraphy. An optimal combination of nuclide activities and acquisition times for ventilation and perfusion, collimators, and imaging matrix yields an adequate V/Q SPECT study in approximately 20 minutes of imaging time. The recommended protocol based on the patient remaining in an unchanged position during the initial ventilation study and the perfusion study allows presentation of matching ventilation and perfusion slices in all projections as well as in rotating volume images based upon maximum intensity projections. Probabilistic interpretation of V/Q SPECT should be replaced by a holistic interpretation strategy on the basis of all relevant information about the patient and all ventilation/perfusion patterns. PE is diagnosed when there is more than one subsegment showing a V/Q mismatch representing an anatomic lung unit. Apart from pulmonary embolism, other pathologies should be identified and reported, for example, obstructive disease, heart failure, and pneumonia. Pitfalls exist both with respect to imaging technique and scan interpretation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20920632     DOI: 10.1053/j.semnuclmed.2010.07.002

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  8 in total

Review 1.  Assessment of Heterogeneity in Lung Structure and Function During Mechanical Ventilation: A Review of Methodologies.

Authors:  Jacob Herrmann; Michaela Kollisch-Singule; Joshua Satalin; Gary F Nieman; David W Kaczka
Journal:  J Eng Sci Med Diagn Ther       Date:  2022-05-11

2.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

3.  Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease.

Authors:  M Bajc; Y Chen; J Wang; X Y Li; W M Shen; C Z Wang; H Huang; A Lindqvist; X Y He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-26

4.  Cocaine-Induced Ventilation/Perfusion Mismatch Mimicking Pulmonary Embolism.

Authors:  Phani Keerthi Surapaneni; Temidayo Abe; Norberto Fas
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

Review 5.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 6.  SPECT/CT and pulmonary embolism.

Authors:  Jann Mortensen; Henrik Gutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-09       Impact factor: 9.236

Review 7.  Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly.

Authors:  Ger T Rijkers; Laura Ie Yousif; Simone Mc Spoorenberg; Frans J van Overveld
Journal:  Risk Manag Healthc Policy       Date:  2018-03-27

8.  Comparison of 81mKrypton and 99mTc-Technegas for ventilation single-photon emission computed tomography in severe chronic obstructive pulmonary disease.

Authors:  Robin de Nijs; Nienke D Sijtsema; Matthijs F Kruis; Claus Verner Jensen; Martin Iversen; Michael Perch; Jann Mortensen
Journal:  Nucl Med Commun       Date:  2021-02-01       Impact factor: 1.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.